世界のプロテイナーゼK市場2020-2027:市場規模、シェア、動向分析

調査会社Grand View Research社が発行したリサーチレポート(データ管理コード:GV21JA129)
◆英語タイトル:Proteinase K Market Size, Share & Trends Analysis Report By Therapeutic Area (Neurology, Oncology, Infectious Diseases), By Form (Powder, Liquid), By Region, And Segment Forecasts, 2020 - 2027
◆発行会社/調査会社:Grand View Research
◆商品コード:GV21JA129
◆発行日:2020年10月15日
◆調査対象地域:グローバル
◆産業分野:医療
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥654,500見積依頼/購入/質問フォーム
Multi UserUSD6,950 ⇒換算¥764,500見積依頼/購入/質問フォーム
Enterprise UserUSD8,950 ⇒換算¥984,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界のプロテイナーゼK市場2020-2027:市場規模、シェア、動向分析]についてメールでお問い合わせはこちら
グランドビューリサーチ社は、プロテイナーゼKの世界市場規模が2027年までに110.43百万ドルに達すると予測しています。2020年から2027年までに年平均7.6%成長する見通しです。本市場調査資料では、プロテイナーゼKの世界市場を広く調査・分析し、調査手法、エグゼクティブサマリー、市場変動・動向・範囲、市場動態、治療領域別(感染症、糖尿病、腫瘍、心臓病、腎臓病)分析、形状別(粉末、液体)分析、地域別分析、競争状況など、以下の構成でまとめております。

・調査手法
・エグゼクティブサマリー
・市場変動・動向・範囲
・市場動態
・プロテイナーゼKの世界市場規模:治療領域別(感染症、糖尿病、腫瘍、心臓病、腎臓病)
・プロテイナーゼKの世界市場規模:形状別(粉末、液体)
・プロテイナーゼKの世界市場規模:地域別
・競争状況
*** レポート概要(サマリー)***

Proteinase K Market Growth & Trends

The global proteinase K market is expected to reach USD 110.43 million by 2027, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 7.6% during the forecast period. Proteinase K is a serine protease commonly applied in the digestion of proteins and the removal of contaminants during nucleic acid preparations. The enzyme can deactivate nucleases that can degrade RNA or DNA during the purification and isolation of nucleic acids.

Proteinase K also finds applications in pre-hybridization processing during in situ hybridization. It works by surrounding and digesting the target DNA protein which increases the probability of binding of probes to the target nucleic acid. This ultimately helps in the improvement of the hybridization signal.

However, an increase in the enzyme’s concentration leads to a subsequent rise in the digestion time. This could lead to damage to the cell structure, shedding of tissue sections, and disappearance of the nucleus as observed during incubation at high temperature. These factors affect the result of hybridization. Therefore, the initial Proteinase K concentration is checked before its use in diagnostic procedures.

Pretreatment with Proteinase K removes the requirement for performing the entire standard protocol for purification and extraction of a COVID-19 sample. The technique has also proved to be efficient and the results produced are as per the standard RT-qPCR method for COVID-19 diagnosis.

North America dominated the overall market in 2019. A well-regulated IVD market coupled with increasing application of molecular IVD techniques is anticipated to positively impact the market growth. Moreover, the local presence of key players that offer diagnostic enzymes is expected to provide growth opportunities to the market. For instance, Creative Enzymes offers a wide range of enzymes that can be used in diagnostics as well as research purposes.

Proteinase K Market Report Highlights

• The infectious disease segment held the largest market share in 2019. The wide adoption of the enzyme in COVID-19 diagnostics is expected to maintain contribute to the dominant share of the segment throughout the forecast period

• The oncology segment also holds a promising market share in 2019 as the proteinase K enzyme is useful for the analysis of cancer specimens. The enzyme has been used to enhance the extraction of RNA from thyroid fine-needle aspiration biopsy specimens and papillary cancer-derived K1 cells

• The neurology segment is expected to expand at the fastest CAGR from 2020 to 2027. The wide adoption of proteinase K for the detection of Multiple System Atrophy (MSA), Parkinson’s disease, Bovine Spongiform Encephalopathy (BSE) proteins, and other prison-related diseases is attributive for the segment growth

• Liquid proteinase K is projected to register the highest CAGR throughout the analysis period. Commonly, the liquid formulation of the enzyme is highly resistant to the effects of detergents and chelating agents. The liquid proteinase K is nonspecific in its degrading effects and is very rigorous. Merck KGaA and Carolina Biological Supply Company offer commercial-grade liquid proteases

• Diagnostic and therapeutic grade enzymes require a high degree of specificity and purity. Therefore, the local manufactures have enhanced their manufacturing and R&D capabilities to provide the highest grade of products

• The key players in the market are involved in novel product launches, acquisition, collaborations, partnerships, and geographical expansions to reinforce their market presence

*** レポート目次(コンテンツ)***

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Model
1.3.1 Parent Market Study
1.3.1.1 Global Enzymes Market
1.3.1.2 Global IVD Market
1.3.1.3 Market Study, By Region
1.4 Objectives
1.4.1 OBJECTIVE 1:
1.4.2 OBJECTIVE 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Trends and Outlook
3.2 Market Segmentation and Scope
3.3 Market Lineage Outlook
3.3.1 Parent Market Analysis
3.3.1.1 IVD Market
3.3.1.2 Molecular Biology Enzymes And Kits Market
3.3.1.3 IVD Enzymes Market
3.3.1.4 Proteases Market
3.4 Pricing Analysis
3.4.1 Pricing and cost considerations
3.4.2 Pricing for Proteinase K: Bulk Order
3.4.3 Pricing for IVD-grade Proteinase K: General Orders
3.4.4 Pricing for Molecular-grade Proteinase K: General Orders
3.5 Impact of COVID-19
3.5.1 Total Number of COVID-19 Tests: Proteinase K, Global (Absolute Number)
3.6 Business Environment Analysis
3.6.1 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
3.6.2 Porter’s Five Forces Analysis
3.7 Penetration and Growth Prospect Mapping for Therapeutic Area, 2019 (USD Million)
Chapter 4 Market Dynamics
4.1 Market driver analysis
4.1.1 Broad applications of molecular diagnostic techniques and their associated enzymes for IVD
4.1.2 Rise in demand for point of care diagnostics coupled with the utility of proteinase K in POC diagnostic tests
4.1.3 Rising incidence of chronic disorders
4.2 Market Restraint Analysis
4.2.1 Reimbursement challenges associated with diagnostic tests
4.3 Market Opportunity Analysis
4.3.1 Applications in molecular biology and other fields
4.4 Market Challenge Analysis
4.4.1 Challenges associated with purification & recovery of enzymes
Chapter 5 Proteinase K Market: Therapeutic Area Estimates & Trend Analysis
5.1 Proteinase K Market: Therapeutic Area Movement Analysis
5.2 Infectious Diseases
5.2.1 Proteinase K market for infectious diseases, 2016 – 2027 (USD Million)
5.3 Diabetes
5.3.1 Proteinase K market for diabetes, 2016 – 2027 (USD Million)
5.4 Oncology
5.4.1 Proteinase K market for oncology, 2016 – 2027 (USD Million)
5.5 Cardiology
5.5.1 Proteinase K market for cardiology, 2016 – 2027 (USD Million)
5.6 Nephrology
5.6.1 Proteinase K market for nephrology, 2016 – 2027 (USD Million)
5.7 Autoimmune Diseases
5.7.1 Proteinase K market for autoimmune diseases, 2016 – 2027 (USD Million)
5.8 Neurology
5.8.1 Proteinase K market for neurology, 2016 – 2027 (USD Million)
5.9 Other therapeutic areas
5.9.1 Proteinase K market for other therapeutic areas, 2016 – 2027 (USD Million)
Chapter 6 Proteinase K Market: Form Estimates & Trend Analysis
6.1 Proteinase K Market: Form Movement Analysis
6.2 Powder
6.2.1 Powdered proteinase K market, 2016 – 2027 (USD Million)
6.3 Liquid
6.3.1 Liquid proteinase K market, 2016 – 2027 (USD Million)
Chapter 7 Proteinase K Market: Regional Estimates & Trend Analysis
7.1 Proteinase K Market: Regional Movement Analysis
7.2 North America
7.2.1 North America proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.2.2.2 U.S. proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.2.2.3 U.S. proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.2.3 Canada
7.2.3.1 Canada proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.2.3.2 Canada proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.2.3.3 Canada proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.3 Europe
7.3.1 Europe proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.3.2 Germany
7.3.2.1 Germany proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.3.2.2 Germany proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.3.2.3 Germany proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.3.3 France
7.3.3.1 France proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.3.3.2 France proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.3.3.3 France proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.3.4 U.K.
7.3.4.1 U.K. proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.3.4.2 U.K. proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.3.4.3 U.K. proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.3.5 Italy
7.3.5.1 Italy proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.3.5.2 Italy proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.3.5.3 Italy proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.3.6 Spain
7.3.6.1 Spain proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.3.6.2 Spain proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.3.6.3 Spain proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.4.2 Japan
7.4.2.1 Japan proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.4.2.2 Japan proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.4.2.3 Japan proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.4.3 China
7.4.3.1 China proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.4.3.2 China proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.4.3.3 China proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.4.4 India
7.4.4.1 India proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.4.4.2 India proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.4.4.3 India proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.5 Latin America
7.5.1 Latin America proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.5.2.2 Brazil proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.5.2.3 Brazil proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.5.3.2 Mexico proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.5.3.3 Mexico proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.6 Middle East & Africa (MEA)
7.6.1 MEA proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.6.2.2 South Africa proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.6.2.3 South Africa proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
Chapter 8 COMPETITIVE LANDSCAPE
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 Merck KGaA
8.3.1.1 Company overview
8.3.1.2 Sigma-Aldrich Co. LLC
8.3.1.2.1 Company overview
8.3.1.3 Financial performance
8.3.1.4 Product benchmarking
8.3.1.5 Strategic initiatives
8.3.2 Codexis
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 F. Hoffmann-La Roche Ltd.
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 Amano Enzymes
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 Advanced Enzymes Technologies Ltd.
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 Biocatalysts Ltd.
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 Amicogen
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 Dyadic International
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 BBI Solutions
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 Affymetrix
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
8.3.11 American Laboratories
8.3.11.1 Company overview
8.3.11.2 Financial performance
8.3.11.3 Product benchmarking
8.3.11.4 Strategic initiatives

List of Tables

Table 1 Pricing for Proteinase K: Bulk Order (U.S.)
Table 2 Pricing for Proteinase K: Bulk Order (Spain)
Table 3 Pricing for Diagnostics Grade Proteinase K: Bulk Order (China)
Table 4 Pricing for Proteinase K: Bulk Order (China)
Table 5 Pricing for IVD-grade Proteinase K: General Orders (U.S.)
Table 6 Pricing for IVD-grade Proteinase K: General Orders (Canada)
Table 7 Pricing for IVD-grade Proteinase K: General Orders (Germany)
Table 8 Pricing for IVD-grade Proteinase K: General Orders (France)
Table 9 Pricing for IVD-grade Proteinase K: General Orders (U.K.)
Table 10 Pricing for IVD-grade Proteinase K: General Orders (China)
Table 11 Pricing for IVD-grade Proteinase K: General Orders (Japan)
Table 12 Pricing for IVD-grade Proteinase K: General Orders (India)
Table 13 Pricing for IVD-grade Proteinase K: General Orders (Brazil)
Table 14 Pricing for IVD-grade Proteinase K: General Orders (South Africa)
Table 15 Pricing for Molecular-grade Proteinase K: General Orders (5mg/ml)
Table 16 Pricing for Molecular-grade Proteinase K: General Orders (≥10 mg/mL)
Table 17 Pricing for Molecular-grade Proteinase K: General Orders (20mg/ml)
Table 18 Manufacturers introducing Proteinase K products for COVID-19
Table 19 Comparison of the cycle threshold (CT) of the standard procedure and Proteinase K pretreatment for COVID-19 diagnosis
Table 20 Comparison of the HBV DNA yield from different methods
Table 21 North America proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 22 North America proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
Table 23 U.S. proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 24 U.S. proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
Table 25 Canada proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 26 Canada proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
Table 27 Europe proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 28 Europe proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
Table 29 Germany proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 30 Germany proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
Table 31 France proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 32 France proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
Table 33 U.K. proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 34 U.K. proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
Table 35 Italy proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 36 Italy proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
Table 37 Spain proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 38 Spain proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
Table 39 Asia Pacific proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 40 Asia Pacific proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
Table 41 Japan proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 42 Japan proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
Table 43 China proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 44 China proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
Table 45 India proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 46 India proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
Table 47 Latin America proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 48 Latin America proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
Table 49 Brazil proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 50 Brazil proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
Table 51 Mexico proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 52 Mexico proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
Table 53 MEA proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 54 MEA proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
Table 55 South Africa proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 56 South Africa proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation and validation
Fig. 8 Market model for proteinase K market derived from enzymes market
Fig. 9 Penetration of diagnostic enzymes in the global specialty enzymes market
Fig. 10 Market model for proteinase K market derived from the IVD market
Fig. 11 Enzyme demand, by region
Fig. 12 Enzyme suppliers, by country
Fig. 13 Market snapshot (USD Million for 2019)
Fig. 14 Market trends & outlook
Fig. 15 Oncology companion diagnostics market
Fig. 16 Price shift from 5ml to 250 ml of Proteinase K across regions (USD)
Fig. 17 Pricing trend for Proteinase K across regions
Fig. 18 Pricing variation for IVD grade Proteinase K in key countries (average price, USD)
Fig. 19 Total Number of COVID-19 Tests: Proteinase K (Absolute Number)
Fig. 20 SWOT Analysis, By Factor (Political & legal Economic and technological)
Fig. 21 Porter’s Five Forces Analysis
Fig. 22 Penetration and growth prospect mapping for the therapeutic area, 2019 (USD Million)
Fig. 23 proteinase K market drivers impact
Fig. 24 Proteinase K market restraints impact
Fig. 25 Proteinase K market opportunity impact
Fig. 26 proteinase K market challenge impact
Fig. 27 Proteinase K market: Therapeutic area outlook and key takeaways
Fig. 28 Proteinase K market: Therapeutic area movement analysis
Fig. 29 Global proteinase K market for infectious diseases, 2016 - 2027 (USD million)
Fig. 30 Global proteinase K market for diabetes, 2016 - 2027 (USD million)
Fig. 31 Global proteinase K market for oncology, 2016 - 2027 (USD million)
Fig. 32 Global proteinase K market for cardiology, 2016 - 2027 (USD million)
Fig. 33 Global proteinase K market for nephrology, 2016 - 2027 (USD million)
Fig. 34 Global proteinase K market for autoimmune diseases, 2016 - 2027 (USD million)
Fig. 35 Global proteinase K market for neurology, 2016 - 2027 (USD million)
Fig. 36 Global proteinase K market for other therapeutic areas, 2016 - 2027 (USD million)
Fig. 37 Proteinase K market: Form outlook and key takeaways
Fig. 38 Proteinase K market: Form movement analysis
Fig. 39 Global powdered proteinase K market, 2016 - 2027 (USD million)
Fig. 40 Global liquid proteinase K market, 2016 - 2027 (USD million)
Fig. 41 Proteinase K market: Regional outlook and key takeaways
Fig. 42 Proteinase K market: Regional movement analysis
Fig. 43 North America
Fig. 44 North America proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 45 U.S.
Fig. 46 U.S. proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 47 Canada
Fig. 48 Canada proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 49 Europe
Fig. 50 Europe proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 51 Germany
Fig. 52 Germany proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 53 France
Fig. 54 France proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 55 U.K.
Fig. 56 U.K. proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 57 Italy
Fig. 58 Italy proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 59 Spain
Fig. 60 Spain proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 61 Asia Pacific
Fig. 62 Asia Pacific proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 63 Japan
Fig. 64 Japan proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 65 China
Fig. 66 China proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 67 India
Fig. 68 India proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 69 Latin America
Fig. 70 Latin America proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 71 Brazil
Fig. 72 Brazil proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 73 Mexico
Fig. 74 Mexico proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 75 MEA
Fig. 76 MEA proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 77 South Africa
Fig. 78 South Africa proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 79 Strategy framework
Fig. 80 Market participation categorization

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GV21JA129 )"世界のプロテイナーゼK市場2020-2027:市場規模、シェア、動向分析" (英文:Proteinase K Market Size, Share & Trends Analysis Report By Therapeutic Area (Neurology, Oncology, Infectious Diseases), By Form (Powder, Liquid), By Region, And Segment Forecasts, 2020 - 2027)はGrand View Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。